|
Study Finds FDA, CMS Regularly Miss Mandatory Review Timelines
The FDA and Centers for Medicare and Medicaid Services (CMS) continue to struggle — and often fail — to meet statutory deadlines for approving Class III devices and issuing national coverage decisions (NCD), according to a paper in the October issue of Health Affairs that looked at median approval times since the mid-1990s.
Devices & Diagnostics Letter |
|
Register Now
Archives